The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.

Susanne Møller Pedersen; Henneke  Versteeg; Jens C. Nielsen; Peter T. Mortensen; Jens Brock Johansen

The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.

Susanne Møller Pedersen, Henneke Versteeg, Jens C. Nielsen, Peter T. Mortensen, Jens Brock Johansen

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning

Abstrakt

The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.

Originalsprog	Engelsk
Publikationsdato	2011
Antal sider	1
Status	Udgivet - 2011
Begivenhed	European Heart Rhythm Association - Madrid, Spanien, Madrid, Spanien Varighed: 26. jun. 2011 → 29. jun. 2011

Konference

Konference	European Heart Rhythm Association
Lokation	Madrid, Spanien
Land/Område	Spanien
By	Madrid
Periode	26/06/2011 → 29/06/2011

Bibliografisk note

Europace (2011) 13 (suppl 3):NP.doi:10.1093/europace/eur222.

Citationsformater

@conference{3e2776bc196a4ef48bf91d588c65c9d8,

title = "The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.",

abstract = "The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.",

author = "Pedersen, {Susanne M{\o}ller} and Henneke Versteeg and Nielsen, {Jens C.} and Mortensen, {Peter T.} and Johansen, {Jens Brock}",

note = "Europace (2011) 13 (suppl 3):NP.doi:10.1093/europace/eur222.; null ; Conference date: 26-06-2011 Through 29-06-2011",

year = "2011",

language = "English",

}

The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients. / Pedersen, Susanne Møller; Versteeg, Henneke ; Nielsen, Jens C.; Mortensen, Peter T.; Johansen, Jens Brock.

2011. Abstract fra European Heart Rhythm Association, Madrid, Spanien.

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning

TY - ABST

T1 - The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.

AU - Pedersen, Susanne Møller

AU - Versteeg, Henneke

AU - Nielsen, Jens C.

AU - Mortensen, Peter T.

AU - Johansen, Jens Brock

N1 - Europace (2011) 13 (suppl 3):NP.doi:10.1093/europace/eur222.

PY - 2011

Y1 - 2011

N2 - The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.

AB - The Medtronic Sprint Fidelis Lead Advisory Notification has no adverse impact on patient reported outcomes in Danish implantable cardioverter defibrillator patients.

M3 - Conference abstract for conference

Y2 - 26 June 2011 through 29 June 2011

ER -